GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SOFIVA GENOMICS Co Ltd (ROCO:6615) » Definitions » Cyclically Adjusted PS Ratio

SOFIVA GENOMICS Co (ROCO:6615) Cyclically Adjusted PS Ratio : 1.30 (As of Jan. 19, 2025)


View and export this data going back to 2017. Start your Free Trial

What is SOFIVA GENOMICS Co Cyclically Adjusted PS Ratio?

As of today (2025-01-19), SOFIVA GENOMICS Co's current share price is NT$39.55. SOFIVA GENOMICS Co's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec23 was NT$30.49. SOFIVA GENOMICS Co's Cyclically Adjusted PS Ratio for today is 1.30.

The historical rank and industry rank for SOFIVA GENOMICS Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

ROCO:6615' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.28   Med: 1.35   Max: 1.57
Current: 1.31

During the past 11 years, SOFIVA GENOMICS Co's highest Cyclically Adjusted PS Ratio was 1.57. The lowest was 1.28. And the median was 1.35.

ROCO:6615's Cyclically Adjusted PS Ratio is ranked better than
68.91% of 119 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.55 vs ROCO:6615: 1.31

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

SOFIVA GENOMICS Co's adjusted revenue per share data of for the fiscal year that ended in Dec23 was NT$21.845. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is NT$30.49 for the trailing ten years ended in Dec23.

Shiller PE for Stocks: The True Measure of Stock Valuation


SOFIVA GENOMICS Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for SOFIVA GENOMICS Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SOFIVA GENOMICS Co Cyclically Adjusted PS Ratio Chart

SOFIVA GENOMICS Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 1.28 1.34

SOFIVA GENOMICS Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1.34 - - -

Competitive Comparison of SOFIVA GENOMICS Co's Cyclically Adjusted PS Ratio

For the Diagnostics & Research subindustry, SOFIVA GENOMICS Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SOFIVA GENOMICS Co's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, SOFIVA GENOMICS Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where SOFIVA GENOMICS Co's Cyclically Adjusted PS Ratio falls into.



SOFIVA GENOMICS Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

SOFIVA GENOMICS Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=39.55/30.49
=1.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SOFIVA GENOMICS Co's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec23 is calculated as:

For example, SOFIVA GENOMICS Co's adjusted Revenue per Share data for the fiscal year that ended in Dec23 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec23 (Change)*Current CPI (Dec23)
=21.845/129.4194*129.4194
=21.845

Current CPI (Dec23) = 129.4194.

SOFIVA GENOMICS Co Annual Data

Revenue per Share CPI Adj_RevenuePerShare
201412 38.153 99.070 49.841
201512 33.921 99.792 43.992
201612 23.352 101.863 29.669
201712 22.301 104.011 27.749
201812 21.511 105.998 26.264
201912 23.744 108.420 28.343
202012 22.861 109.897 26.922
202112 23.878 117.630 26.271
202212 23.191 125.222 23.968
202312 21.845 129.419 21.845

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


SOFIVA GENOMICS Co  (ROCO:6615) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


SOFIVA GENOMICS Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of SOFIVA GENOMICS Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


SOFIVA GENOMICS Co Business Description

Traded in Other Exchanges
N/A
Address
No. 66-1, Sec. 1, Chongqing S. Road, 4th Floor, Zhongzheng District, Taipei, TWN, 10043
SOFIVA GENOMICS Co Ltd provides medical diagnostic services. The services offered by the company include Prenatal, Reproductive, Cancer, Precision medicine, Newborn, and Rare Diseases. Its testing categories include Genetic, Biochemical, and Chromosome. The business items of Sofiva Group are pre-pregnancy, pre-natal and neonatal genetic testing and medical testing and other service income. Geographically, it generates the vast majority of its revenue from Taiwan.

SOFIVA GENOMICS Co Headlines

No Headlines